Table 3.
Laboratory parameters after initiation of ECMO support (from Feb 7th to Apr 14th).
| Events or parameters | 7-Feb | 13-Feb | 23-Feb | 29-Feb | 1-Mar | 2-Mar | 10-Mar | 20-Mar | 21-Mar | 22-Mar | 23-Mar | 31-Mar | 6-Apr | 14-Apr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of hospitalization/ | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | |
| day of ECMO | 9/2 | 15/8 | 25/18 | 31/24 | 32/25 | 33/26 | 41/34 | 51/44 | 52/45 | 53/46 | 54/47 | 62 | 68 | 76 | |
| Clinical event | D/C NMBA | Restart ECMO AF | NMBA | D/C NMBA | Wean ECMO | ||||||||||
| Clamp ECMO AF | Clamp ECMO AF | ||||||||||||||
| Inflammation | Tmax (°C) | 37.0 | 38.4 | 37.4 | 37.5 | 38.0 | 37.3 | 36.8 | 37.4 | 37.5 | 37.6 | 38.2 | 37.3 | 37.0 | 36.7 |
| CRP (mg/dL) | 4.14 | 8.52 | 6.74 | 7.00 | 9.14 | 10.55 | 4.75 | 1.91 | 1.97 | 2.68 | 1.53 | 1.62 | 0.59 | 0.87 | |
| WBC (×10∧9/L) | 7.98 | 6.77 | 8.86 | 7.69 | 7.91 | 7.76 | 9.06 | 7.43 | 6.88 | 7.92 | 7.2 | 6.4 | 7.55 | 7.27 | |
| Lymphocyte count (×10∧9/L) | 0.44 | 0.53 | 0.85 | 0.58 | 0.65 | 0.66 | 1.13 | 1.91 | 1.61 | 2.32 | 2.36 | 1.65 | 1.96 | 2.78 | |
| PCT (ng/ml) | 0.09 | 0.49 | 0.08 | 0.17 | 0.16 | 0.17 | 0.48 | 0.41 | 0.35 | 0.27 | 0.23 | 0.11 | 0.06 | 0.05 | |
| IL-6 (pg/ml) | 135.94 | 123.00 | 26.45 | 4.93 | |||||||||||
| Immunity | IgA (mg/L) | 1.37 | 3.00 | 2.86 | 2.72 | 2.57 | 2.18 | 2 | 1.91 | ||||||
| IgG (mg/L) | 17 | 14.60 | 13.90 | 13.90 | 12.60 | 11.10 | 12.8 | 14.2 | |||||||
| IgM (mg/L) | 0.62 | 2.56 | 1.80 | 1.69 | 1.47 | 0.97 | 0.98 | 1.26 | |||||||
| CD3 (/ul) | 130 | 265 | 533 | 381 | 364 | 393 | 668 | 1,267 | 1,469 | ||||||
| CD8 (/ul) | 63 | 101 | 214 | 162 | 148 | 176 | 370 | 989 | 1,149 | ||||||
| CD4 (/ul) | 63 | 158 | 308 | 201 | 202 | 210 | 278 | 247 | 308 | ||||||
D/C, discontinue; NMBA, neuromuscular blockade agent; ECMO, extracorporeal membrane oxygenation; CRP, C-reactive protein; WBC, white blood cell count; PCT, procalcitonin; IL-6, interleukin-6.